Patent ID: 11939335
Assignee: 858 THERAPEUTICS, INC.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C | IPC A  C

Claim 24:
25. The compound of claim 1, or a pharmaceutically acceptable salt, deuteroisotope, or stereoisomer thereof, wherein any R4 and R5, taken together with the carbon atom to which they are attached, independently forms a carbocyclyl or heterocyclyl, wherein each carbocyclyl or heterocyclyl is optionally and independently substituted with one or more substituents independently selected from the group consisting of D, halo, CN, NO2, alkyl, haloalkyl, alkenyl, haloalkenyl, alkynyl, haloalkynyl, C(O)Ra, C(O)N(Ra)2, C(O)ORa, N(Ra)2, NRaC(O)Ra, NRaC(O)ORa, NRaS(O)tRa, ORa, OC(O)Ra, OC(O)N(Ra)2, OC(O)ORa, ORcC(O)N(Ra)2, ═O, S(O)tRa, S(O)tN(Ra)2, S(O)tORa, ═S, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl.